Report period | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
GHSI:US | Guardion Health Sciences | Common share | - | US40145Q2030 | $7.99 |
Company name | Guardion Health Sciences |
---|---|
Tags | #pharmacy, #ophthalmology, #medical equipment |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | 15150 Avenue of Science Suite 200 San Diego, CA 92128 United States |
Mailing address | 15150 Avenue of Science Suite 200 San Diego, CA 92128 United States |
Website | investors.guardionhealth.com |